CAS 1575596-29-0

Rilzabrutinib

CAS : 1575596-29-0

(R,E)-2-(3-(4-Amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile

Formule : C₃₆H₄₀FN₉O₃

Degré de pureté : 99.0%

Masse moléculaire : 665.76

Ref: IN-DG00812358

Rilzabrutinib

CAS : 1575596-29-0

Rilzabrutinib (PRN1008) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM).

Formule : C₃₆H₄₀FN₉O₃

Degré de pureté : 98.28% - 99.76%

Couleur et forme : White Solid

Masse moléculaire : 665.76

Ref: TM-T12542

Rilzabrutinib

CAS : 1575596-29-0

Rilzabrutinib

Formule : C₃₆H₄₀FN₉O₃

Degré de pureté : ≥95%

Masse moléculaire : 665.76

Ref: 54-BUP08990

PRN1008

CAS : 1575596-29-0

PRN1008 is a small molecule that acts as an inhibitor of methyltransferases. It is a powerful, irreversible inhibitor of the enzyme and has shown to be efficacious in treating infectious diseases such as tuberculosis and malaria. PRN1008 has also been shown to be effective in treating autoimmune diseases, cancer, and inflammatory diseases. The drug is currently undergoing clinical trials for its effects on hematopoietic cells and activity index.

Formule : C₃₆H₄₀FN₉O₃

Degré de pureté : (Lc-Ms) Min. 98 Area-%

Couleur et forme : Powder

Masse moléculaire : 665.76 g/mol

Ref: 3D-FP167893